4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-027601
EVP and Chief Legal Officer sold 4,378 shares at $45.00 ($197,010)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parschauer Karah Herdman EVP and Chief Legal Officer | 2023-05-04 | Sale | −4,378 | $45.00 | $197,010 | 51,982 | D: show line 1 in the form |
| Open-market sales · 4,378 sh · avg $45.00 · $197,010 | |||||||
Loading xslF345X04/doc4.xml…